Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study

Metabolism: Clinical and Experimental

Volumn 57, Issue 3, 2008, Pages 428-436

  Kilpelainen TuomasO ^a   Lakka, TimoA ^a   Laaksonen, DavidE ^a,b   Mager, Ursula ^a   Salopuro, Titta ^a   Kubaszek, Agata ^b   Todorova, Boryana ^b   Laukkanen, Olli ^b   Lindström, Jaana ^c   Eriksson, JohanG ^c,d   Hämäläinen, Helena ^e   Aunola, Sirkka ^c   Ilanne Parikka, Pirjo ^f,g   Keinänen Kiukaanniemi, Sirkka ^h,i   Tuomilehto, Jaako ^c,d,j   Laakso, Markku ^b   Uusitupa, Matti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e SOCIAL INSURANCE INSTITUTION   (Finland)

^f Finnish Diabetes Association   (Finland)

^g PIRKANMAA HOSPITAL DISTRICT   (Finland)

^h UNIVERSITY OF OULU   (Finland)

ⁱ OULU DEACONESS INSTITUTE   (Finland)

^j SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2B ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; GHRELIN; INTERLEUKIN 6; LEPTIN RECEPTOR; LIVER TRIACYLGLYCEROL LIPASE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE FREQUENCY; GLUCOSE INTOLERANCE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 38749153653     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.10.022     Document Type: Article

References (55)

1. Tuomilehto J., Lindström J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
2. Lindi V.I., Uusitupa M.I., Lindström J., et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention study. Diabetes 51 (2002) 2581-2586
3. Siitonen N., Lindström J., Eriksson J., et al. Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia 47 (2004) 1416-1424
4. Salopuro T., Lindström J., Eriksson J.G., et al. Common variants in beta2- and beta3-adrenergic receptor genes and uncoupling protein 1 as predictors of the risk for type 2 diabetes and body weight changes. The Finnish Diabetes Prevention Study. Clin Genet 66 (2004) 365-367
5. Kubaszek A., Pihlajamäki J., Komarovski V., et al. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: The Finnish Diabetes Prevention Study. Diabetes 52 (2003) 1872-1876
6. Laukkanen O., Pihlajamäki J., Lindström J., et al. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia 47 (2004) 871-877
7. Todorova B., Kubaszek A., Pihlajamäki J., et al. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus. The Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 89 (2004) 2019-2023
8. Salopuro T., Pulkkinen L., Lindström J., et al. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight. The Finnish Diabetes Prevention Study. Int J Obes (Lond) 29 (2005) 1245-1251
9. Laukkanen O., Pihlajamäki J., Lindström J., et al. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 89 (2004) 6286-6290
10. Laukkanen O., Lindström J., Eriksson J., et al. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetes 54 (2005) 2256-2260
11. Mager U., Lindi V., Lindström J., et al. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study. Diabet Med 23 (2006) 685-689
12. Bouchard C., and Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc 33 (2001) S446-S451 [discussion S452-3]
13. Laaksonen D.E., Lindström J., Lakka T.A., et al. Physical activity in the prevention of type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetes 54 (2005) 158-165
14. Laaksonen D.E., Siitonen N., Lindström J., et al. Physical activity, diet, and incident diabetes in relation to an ADRA2B polymorphism. Med Sci Sports Exerc 39 (2007) 227-232
15. Kilpeläinen T.O., Lakka T.A., Laaksonen D.E., et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol Genomics 31 (2007) 264-272
16. Ilanne-Parikka P., Eriksson J.G., Lindström J., et al. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 27 (2004) 2135-2140
17. Lakka T.A., and Laaksonen D.E. Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 32 (2007) 76-88
18. Eriksson J., Lindström J., Valle T., et al. Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 42 (1999) 793-801
19. Lindström J., Louheranta A., Mannelin M., et al. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26 (2003) 3230-3236
20. WHO. Diabetes mellitus. Report of a WHO study group. World Health Organ Tech Rep Ser 727 (1985) 1-113
21. Mager U., Kolehmainen M., Lindström J., et al. Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance. Am J Hypertens 19 (2006) 920-926
22. Lakka T.A., and Salonen J.T. Intra-person variability of various physical activity assessments in the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Epidemiol 21 (1992) 467-472
23. Pereira M.A., FitzerGerald S.J., Gregg E.W., et al. A collection of physical activity questionnaires for health-related research. Med Sci Sports Exerc 29 (1997) S1-S205
24. Lindström J., Ilanne-Parikka P., Peltonen M., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368 (2006) 1673-1679
25. Laaksonen D.E., Nyyssönen K., Niskanen L., et al. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 165 (2005) 193-199
26. McKenzie J.A., Weiss E.P., Ghiu I.A., et al. Influence of the interleukin-6 ?174 G/C gene polymorphism on exercise training-induced changes in glucose tolerance indexes. J Appl Physiol 97 (2004) 1338-1342
27. Teran-Garcia M., Santoro N., Rankinen T., et al. Hepatic lipase gene variant -514C>T is associated with lipoprotein and insulin sensitivity response to regular exercise: the HERITAGE Family Study. Diabetes 54 (2005) 2251-2255
28. Lakka T.A., Rankinen T., Weisnagel S.J., et al. Leptin and leptin receptor gene polymorphisms and changes in glucose homeostasis in response to regular exercise in nondiabetic individuals: the HERITAGE Family Study. Diabetes 53 (2004) 1603-1608
29. Takaya K., Ariyasu H., Kanamoto N., et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85 (2000) 4908-4911
30. Jorgensen J.O., Vahl N., Hansen T.B., et al. Influence of growth hormone and androgens on body composition in adults. Horm Res 45 (1996) 94-98
31. Wren A.M., Seal L.J., Cohen M.A., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86 (2001) 5992
32. Lassarre C., Girard F., Durand J., et al. Kinetics of human growth hormone during submaximal exercise. J Appl Physiol 37 (1974) 826-830
33. Dall R., Kanaley J., Hansen T.K., et al. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. Eur J Endocrinol 147 (2002) 65-70
34. Foster-Schubert K.E., McTiernan A., Frayo R.S., et al. Human plasma ghrelin levels increase during a one-year exercise program. J Clin Endocrinol Metab 90 (2005) 820-825
35. Leidy H.J., Gardner J.K., Frye B.R., et al. Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. J Clin Endocrinol Metab 89 (2004) 2659-2664
36. Mackelvie K.J., Meneilly G.S., Elahi D., et al. Regulation of appetite in lean and obese adolescents after exercise: Role of acylated and desacyl ghrelin. J Clin Endocrinol Metab 92 (2007) 648-654
37. van der Lely A.J., Tschop M., Heiman M.L., et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25 (2004) 426-457
38. Purnell J.Q., Cummings D., and Weigle D.S. Changes in 24-h area-under-the-curve ghrelin values following diet-induced weight loss are associated with loss of fat-free mass, but not with changes in fat mass, insulin levels or insulin sensitivity. Int J Obes (Lond) 31 (2007) 385-389
39. Moran L.J., Luscombe-Marsh N.D., Noakes M., et al. The satiating effect of dietary protein is unrelated to postprandial ghrelin secretion. J Clin Endocrinol Metab 90 (2005) 5205-5211
40. Tang-Christensen M., Vrang N., Ortmann S., et al. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 145 (2004) 4645-4652
41. Leon A.S., Gaskill S.E., Rice T., et al. Variability in the response of HDL cholesterol to exercise training in the HERITAGE Family Study. Int J Sports Med 23 (2002) 1-9
42. Purnell J.Q., Weigle D.S., Breen P., et al. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 88 (2003) 5747-5752
43. Pöykkö S.M., Kellokoski E., Horkko S., et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52 (2003) 2546-2553
44. St-Pierre D.H., Faraj M., Karelis A.D., et al. Lifestyle behaviours and components of energy balance as independent predictors of ghrelin and adiponectin in young non-obese women. Diabetes Metab 32 (2006) 131-139
45. Choi H.J., Cho Y.M., Moon M.K., et al. Polymorphisms in the ghrelin gene are associated with serum high-density lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans. J Clin Endocrinol Metab 91 (2006) 4657-4663
46. Beaumont N.J., Skinner V.O., Tan T.M., et al. Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. J Biol Chem 278 (2003) 8877-8880
47. Avallone R., Demers A., Rodrigue-Way A., et al. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway. Mol Endocrinol 20 (2006) 3165-3178
48. de Luis Roman D., de la Fuente R.A., Sagrado M.G., et al. Leptin receptor Lys656Asn polymorphism is associated with decreased leptin response and weight loss secondary to a lifestyle modification in obese patients. Arch Med Res 37 (2006) 854-859
49. Margetic S., Gazzola C., Pegg G.G., et al. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26 (2002) 1407-1433
50. Grassi G. Leptin, sympathetic nervous system, and baroreflex function. Curr Hypertens Rep 6 (2004) 236-240
51. Rahmouni K., Correia M.L., Haynes W.G., et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension 45 (2005) 9-14
52. Eikelis N., Schlaich M., Aggarwal A., et al. Interactions between leptin and the human sympathetic nervous system. Hypertension 41 (2003) 1072-1079
53. Ishii T., Yamakita T., Yamagami K., et al. Effect of exercise training on serum leptin levels in type 2 diabetic patients. Metabolism 50 (2001) 1136-1140
54. Pasman W.J., Westerterp-Plantenga M.S., and Saris W.H. The effect of exercise training on leptin levels in obese males. Am J Physiol 274 (1998) E280-E286
55. Laaksonen D.E., Lakka H.M., Lynch J., et al. Cardiorespiratory fitness and vigorous leisure-time physical activity modify the association of small size at birth with the metabolic syndrome. Diabetes Care 26 (2003) 2156-2164